Physician

Alexander Ernst, M.D.

According to 2025 Medicare claims, Alexander Ernst, M.D. (NPI: 1376923193) practices dermatology in the Warren-Troy-Farmington Hills, MI market, with the plurality of this provider's patient population coming from Oakland, MI. This provider's primary affiliated billing organization is MICHIGAN HEALTHCARE PROFESSIONALS PC (NPI: 1295023547; TIN: 451674932) and primary practice location at 48307-9998. Ernst is affiliated with the Honest ACO of Michigan LLC (ACO ID: D0236), participating under the REACH model.

Ernst's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 401 traditional Medicare patients, billed 1,720 HCPCS/CPT codes, and received $98,775 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 2,678 prescription claims across 676 beneficiaries totaling $1,632,565 in drug costs, led by Skyrizi Pen (Risankizumab-Rzaa). Open Payments data shows 101 records totaling $1,923. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $7,540 to $98,775. Similarly, Part D prescription costs have risen steadily, from $449 to $1,632,565. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$49K$99K2019 Medicare payment: $7,540 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $42,526 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $69,799 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $69,178 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $84,438 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $98,775 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
201941124$7,540
2020194680$42,526
20212641,172$69,799
20222821,170$69,178
20233611,465$84,438
20244011,720$98,775

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$816K$1.6M2015 Drug cost: $449 (USD; Tot_Drug_Cst)2016 Drug cost: $13,931 (USD; Tot_Drug_Cst)2017 Drug cost: $71,190 (USD; Tot_Drug_Cst)2018 Drug cost: $10,580 (USD; Tot_Drug_Cst)2019 Drug cost: $10,740 (USD; Tot_Drug_Cst)2020 Drug cost: $23,188 (USD; Tot_Drug_Cst)2021 Drug cost: $66,089 (USD; Tot_Drug_Cst)2022 Drug cost: $310,575 (USD; Tot_Drug_Cst)2023 Drug cost: $777,384 (USD; Tot_Drug_Cst)2024 Drug cost: $1,632,565 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/R14$449
20165799$13,931
2017110278$71,190
201853146$10,580
201958152$10,740
2020203577$23,188
2021295994$66,089
20223941,284$310,575
20235341,996$777,384
20246762,678$1,632,565

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths121158$78
99203New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more127127$71
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more171245$65
11102Biopsy of related skin growth, first growth130156$58
17000Destruction of precancer skin growth, 1 growth129153$33

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Skyrizi PenRisankizumab-Rzaa272,156$535,041
Humira(Cf) PenAdalimumab20560$267,536
Dupixent PenDupilumab701,834$260,292
Cosentyx Unoready PenSecukinumab18504$196,829
Cosentyx Sensoready (2 Pens)Secukinumab11308$80,383

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.101$1,923ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Alexander Ernst, M.D.?

Tedicare shows public-source Medicare data for Alexander Ernst, M.D. (NPI 1376923193), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alexander Ernst, M.D. have ACO affiliation data?

Alexander Ernst, M.D. is shown with ACO affiliation data for Honest ACO of Michigan LLC (REACH, ACO ID D0236).

What billing organization is linked to Alexander Ernst, M.D.?

Alexander Ernst, M.D. is linked to MICHIGAN HEALTHCARE PROFESSIONALS PC (billing NPI 1295023547) in the available physician profile data.

Does Alexander Ernst, M.D. have Open Payments data?

Alexander Ernst, M.D. has 101 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.